Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in

M H Olsen1, E Hjerkinn, K Wachtell

  • 1Department of Clinical Physiology and Nuclear Medicine, Glostrup University Hospital, Copenhagen, Denmark. mho@dadlnet.dk

Insights

Systemic vascular hypertrophy, not insulin resistance, is linked to abnormal left ventricular (LV) geometry in hypertensive patients. Common carotid artery thickness correlates with LV hypertrophy and diastolic dysfunction.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Metabolic Syndrome

Background:

  • Vascular hypertrophy and insulin resistance are linked to abnormal left ventricular (LV) geometry.
  • Hypertension is a major risk factor for cardiovascular disease and LV hypertrophy.

Purpose of the Study:

  • To investigate the influence of vascular hypertrophy and insulin resistance on LV hypertrophy and function in hypertensive patients.
  • To explore the relationship between common carotid artery intima-media thickness (IMA), minimal forearm vascular resistance (MFVR), and LV parameters.

Main Methods:

  • Eighty-nine patients with essential hypertension and electrocardiographic LV hypertrophy were studied.
  • Measurements included blood pressure, insulin sensitivity (hyperinsulinaemic euglucaemic clamp), MFVR, IMA (ultrasound), and LV mass, RWT, systolic, and diastolic function (echocardiography).

Main Results:

  • LV mass index correlated with IMA/height, serum insulin, and plasma glucose, but not MFVR.
  • Deceleration time of early diastolic transmitral flow positively correlated with IMA/height.
  • Early diastolic LV filling parameters correlated with MFVR in men.
  • Systolic LV function was not related to vascular parameters or insulin resistance markers.

Conclusions:

  • Insulin resistance was not directly related to LV hypertrophy or reduced LV function in this cohort.
  • Systemic vascular hypertrophy, indicated by common carotid artery thickness, is associated with LV hypertrophy and impaired diastolic relaxation.
  • Increased MFVR is linked to altered diastolic LV filling patterns, suggesting a role for vascular hypertrophy in diastolic dysfunction in hypertensive patients.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...